BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20564074)

  • 21. Mucins and associated O-glycans based immunoprofile for stratification of colorectal polyps: clinical implication for improved colon surveillance.
    Krishn SR; Kaur S; Sheinin YM; Smith LM; Gautam SK; Patel A; Jain M; Juvvigunta V; Pai P; Lazenby AJ; Roy HK; Batra SK
    Oncotarget; 2017 Jan; 8(4):7025-7038. PubMed ID: 27705923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular pathways driving disease-specific alterations of intestinal epithelial cells.
    López-Posadas R; Neurath MF; Atreya I
    Cell Mol Life Sci; 2017 Mar; 74(5):803-826. PubMed ID: 27624395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer.
    Pai P; Rachagani S; Dhawan P; Sheinin YM; Macha MA; Qazi AK; Chugh S; Ponnusamy MP; Mallya K; Pothuraju R; Batra SK
    Genes Cancer; 2016 May; 7(5-6):154-168. PubMed ID: 27551331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma.
    Fu H; Liu Y; Xu L; Chang Y; Zhou L; Zhang W; Yang Y; Xu J
    Medicine (Baltimore); 2016 Apr; 95(17):e3225. PubMed ID: 27124015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.
    Krishn SR; Kaur S; Smith LM; Johansson SL; Jain M; Patel A; Gautam SK; Hollingsworth MA; Mandel U; Clausen H; Lo WC; Fan WT; Manne U; Batra SK
    Cancer Lett; 2016 May; 374(2):304-14. PubMed ID: 26898938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucins and Wnt/β-catenin signaling in gastrointestinal cancers: an unholy nexus.
    Pai P; Rachagani S; Dhawan P; Batra SK
    Carcinogenesis; 2016 Mar; 37(3):223-32. PubMed ID: 26762229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyper Expression of Mucin 5ac Indicates Poor Cancer Prognoses: A Meta-Analysis.
    Wang X; Yan F; Shi R; Huang X; Lu S; Xu L; Ren B
    Medicine (Baltimore); 2016 Jan; 95(1):e2396. PubMed ID: 26735541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological and prognostic significance of MUC4 expression in cancers: evidence from meta-analysis.
    Huang X; Wang X; Lu SM; Chen C; Wang J; Zheng YY; Ren BH; Xu L
    Int J Clin Exp Med; 2015; 8(7):10274-83. PubMed ID: 26379819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer.
    Das S; Rachagani S; Sheinin Y; Smith LM; Gurumurthy CB; Roy HK; Batra SK
    Oncogene; 2016 May; 35(20):2645-54. PubMed ID: 26364605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive expression analysis of mucins in appendiceal carcinoma in a multicenter study: MUC3 is a novel prognostic factor.
    Shibahara H; Higashi M; Yokoyama S; Rousseau K; Kitazono I; Osako M; Shirahama H; Tashiro Y; Kurumiya Y; Narita M; Kuze S; Hasagawa H; Kato T; Kubota H; Suzuki H; Arai T; Sakai Y; Yuasa N; Fujino M; Kondo S; Okamoto Y; Yamamoto T; Hiromatsu T; Sasaki E; Shirai K; Kawai S; Hattori K; Tsuji H; Okochi O; Sakamoto M; Kondo A; Konishi N; Batra SK; Yonezawa S
    PLoS One; 2014; 9(12):e115613. PubMed ID: 25551773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological utility of sialoglycoconjugates in diagnosing and treating colorectal cancer.
    Inagaki Y; Gao J; Song P; Kokudo N; Nakata M; Tang W
    World J Gastroenterol; 2014 May; 20(20):6123-32. PubMed ID: 24876734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas.
    Kitazono I; Higashi M; Kitamoto S; Yokoyama S; Horinouchi M; Osako M; Shimizu T; Tabata M; Batra SK; Goto M; Yonezawa S
    Pancreas; 2013 Oct; 42(7):1120-8. PubMed ID: 23921963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmembrane mucin MUC1 overexpression and its association with CD10⁺ myeloid cells, transforming growth factor-β1 expression, and tumor budding grade in colorectal cancer.
    Khanh do T; Mekata E; Mukaisho K; Sugihara H; Shimizu T; Shiomi H; Murata S; Naka S; Yamamoto H; Endo Y; Tani T
    Cancer Sci; 2013 Jul; 104(7):958-64. PubMed ID: 23566254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy.
    Algamas-Dimantov A; Yehuda-Shnaidman E; Peri I; Schwartz B
    Cell Oncol (Dordr); 2013 Apr; 36(2):155-67. PubMed ID: 23307400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer.
    Tamura Y; Higashi M; Kitamoto S; Yokoyama S; Osako M; Horinouchi M; Shimizu T; Tabata M; Batra SK; Goto M; Yonezawa S
    PLoS One; 2012; 7(11):e49251. PubMed ID: 23152882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of membrane-associated mucins 1 and 4 in gastric adenocarcinoma.
    Hwang I; Kang YN; Kim JY; DO YR; Song HS; Park KU
    Exp Ther Med; 2012 Aug; 4(2):311-316. PubMed ID: 23139719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable stage III colorectal adenocarcinomas.
    Katkoori VR; Shanmugam C; Jia X; Vitta SP; Sthanam M; Callens T; Messiaen L; Chen D; Zhang B; Bumpers HL; Samuel T; Manne U
    PLoS One; 2012; 7(1):e30020. PubMed ID: 22276141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and progression of colorectal neoplasia.
    Manne U; Shanmugam C; Katkoori VR; Bumpers HL; Grizzle WE
    Cancer Biomark; 2010; 9(1-6):235-65. PubMed ID: 22112479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of mucin 4 expression in colorectal adenocarcinomas.
    Shanmugam C; Jhala NC; Katkoori VR; Wan W; Meleth S; Grizzle WE; Manne U
    Cancer; 2010 Aug; 116(15):3577-86. PubMed ID: 20564074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
    Manne U; Weiss HL; Grizzle WE
    Clin Cancer Res; 2000 Oct; 6(10):4017-25. PubMed ID: 11051251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.